Trending

U.S FDA has granted 510 (k) clearance to Bio-Rad Laboratories for the IH-Incubator L and IH-Centrifuge L instruments to be used with the full range of Bio-Rad’s IH-System Gel Reagents…
Read More...

Enzychem Lifesciences Corp asserted that the US Food and Drug Administration has granted Orphan Drug Designation to EC-18 for treating Acute Radiation Syndrome. US FDA Orphan Drug…
Read More...

Boston-based Biopharmaceutical company, BERG proclaimed that the U.SS FDA has extended orphan-drug designation to the Company's leading product candidate BPM31510, for the treatment of…
Read More...

Clinical stage Biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary diseases, Pulmatrix sought approval of its Clinical Trial Application from…
Read More...

Medrobotics Corporation asserted that FDA has granted clearance to promulgate the Flex Robotics System for robot-assisted visualization in general surgical, gynecological and thoracic…
Read More...

Bristol-Myers Squibb Company asserted new data from a cohort of the Phase 2 CheckMate-142 trial assessing Opdivo and Yervoy for the treatment of patients with DNA mismatch repair…
Read More...

SymBio Pharmaceuticals commences a Phase 1 study in Japan for oral TREAKISYM in progressive solid tumors afflicted patients. SymBio sought approval for TREAKISYM injectables…
Read More...

In a bid to offer qualitative bioanalytical and DMPK study services, Concept Life Sciences and Alderly Analytical venture into partnership agreement enumerating having access to…
Read More...

Aquestive Therapeutics proclaimed the acceptance of New drug application for clobazam Oral Soluble Film (clobazam OSF) treating seizures associated with Lennox-Gastaut syndrome (LGS) in…
Read More...

QIAGEN N.V declared the U.S FDA's approval of PMA supplement augmenting indications for use of QIAGEN's therascreen EGFR RGQ PCR kit as a diagnostic to direct the use of  Boehringer…
Read More...

Private medical technology company, Bluegrass Vascular Technologies emphasizing on developing innovating lifesaving devices and methods for vascular access asserted the enrollment of…
Read More...

In a bid to develop contrast agents with reduced renal toxicity, Ligand Pharmaceuticals set to initiate a program to develop contrast agents with lessened renal toxicity. Enabling usage…
Read More...

Pandion Therapeutics declared the completion of a $58 million Series A financing that will be utilized to further its drug programs for autoimmune and inflammatory diseases in addition…
Read More...

A Gilead Company, Kite ventures into Clinical Trial collaboration with  Pfizer, enabling assessment of the efficacy of the investigational combination of Yescarta (axicabtagene…
Read More...

Makers of the the Prenate line of prescription prenatal vitamins, Avion Pharmaceuticals sought approval of its New Drug application for the Oral Contraceptive Balcoltra (levonorgestrel…
Read More...

Clinical stage company, Relmada Therapeutics into developing novel therapies for treating Centralnervous system diseases obtained global rights to develop and market dextromethadone…
Read More...

Molecule discovery specialist X-Chem, proclaimed a remarkable extension of their present drug discovery collaboration with AstraZeneca. The agreement focuses on the synthesis and…
Read More...

Digital patient decision support platform, WiserCare declared the appointment of Daniel J. Castillo as its Chief Executive Officer.  He brings with him profound experience and knowledge…
Read More...

A biotech company that designs and develops virus-based  immunotherapies, Transgene confirms dosing the first patient in  a Phase 1 Clinical Trial in China, evaluating T101, therapeutic…
Read More...

Ipsen bio-pharmaceuticals set to present five new sub-analyses of the pivotal Phase 3 NAPOLI-1 trial at this year's American Society of Clinical Oncology’s Gastrointestinal Cancer…
Read More...